Increasing antimicrobial resistance in nontyphoidal salmonella isolates in Australia from 1979 to 2015

Antimicrobial Agents and Chemotherapy

Volumn 62, Issue 2, 2018, Pages

  Williamson, Deborah A ^a   Lane, Courtney R ^a   Easton, Marion ^b   Valcanis, Mary ^a   Strachan, Janet ^b   Veitch, Mark G ^b   Kirk, Martyn D ^c   Howden, Benjamin P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Department of Health and Human Services ^*  (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Antimicrobial resistance; Epidemiology; Public health; Salmonella; Salmonella enterica; Surveillance studies; Zoonotic infections

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CIPROFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CORRELATION ANALYSIS; EPIDEMIOLOGICAL MONITORING; HUMAN; LONGITUDINAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE; SOUTHEAST ASIA; TRAVEL; TREND STUDY; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-BACTERIAL AGENTS; AUSTRALIA; CEFOTAXIME; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEROGROUP;

EID: 85041078006     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02012-17     Document Type: Article

References (29)

1. Crump JA, Sjolund-Karlsson M, Gordon MA, Parry CM. 2015. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev 28:901–937. https://doi.org/10.1128/CMR.00002-15.
2. Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. 2015. Global burden of invasive nontyphoidal Salmonella disease, 2010. Emerg Infect Dis 21(6). https://doi.org/10.3201/eid2106.140999.
3. Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D’Angelo M, Hurd S, Medus C, Cronquist A, Angulo FJ. 2008. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 198:109–114. https://doi.org/10.1086/588823.
4. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, Barzilay EJ, Emerging Infections Program NARMS Working Group. 2011. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother 55: 1148–1154. https://doi.org/10.1128/AAC.01333-10.
5. Ceyssens PJ, Mattheus W, Vanhoof R, Bertrand S. 2015. Trends in serotype distribution and antimicrobial susceptibility in Salmonella enterica isolates from humans in Belgium, 2009 to 2013. Antimicrob Agents Chemother 59:544–552. https://doi.org/10.1128/AAC.04203-14.
6. World Health Organisation. 2014. Antimicrobial Resistance. Global report on surveillance. World Health Organisation, Geneva, Switzerland. http://www.who.int/drugresistance/documents/surveillancereport/en/.
7. Centers for Disease Prevention and Control. 2014. Antibiotic resistance threats in the United States 2013. Centers for Disease Prevention and Control, Atlanta, GA. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
8. Le Hello S, Bekhit A, Granier SA, Barua H, Beutlich J, Zajac M, Munch S, Sintchenko V, Bouchrif B, Fashae K, Pinsard JL, Sontag L, Fabre L, Garnier M, Guibert V, Howard P, Hendriksen RS, Christensen JP, Biswas PK, Cloeckaert A, Rabsch W, Wasyl D, Doublet B, Weill FX. 2013. The global establishment of a highly-fluoroquinolone resistant Salmonella enterica serotype Kentucky ST198 strain. Front Microbiol 4:395. https://doi.org/10.3389/fmicb.2013.00395.
9. Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, Brown DJ, Coia JE, Mulvey MR, Gilmour MW, Petrovska L, de Pinna E, Kuroda M, Akiba M, Izumiya H, Connor TR, Suchard MA, Lemey P, Mellor DJ, Haydon DT, Thomson NR. 2013. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 341: 1514–1517. https://doi.org/10.1126/science.1240578.
10. National Notifiable Disease Surveillance System, Department of Health and Ageing, Canberra. Notifications for all disease by State & Territory and year. http://www9.health.gov.au/cda/source/cda-index.cfm.
11. Crim SM, Iwamoto M, Huang JY, Griffin PM, Gilliss D, Cronquist AB, Cartter M, Tobin-D’Angelo M, Blythe D, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Lance S, Tauxe R, Henao OL. 2014. Incidence and trends of infection with pathogens transmitted commonly through food—Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2013. MMWR Morb Mortal Wkly Rep 63:328–332.
12. Public Health England. 2016. Salmonella data 2006 to 2015: National Laboratory data for residents of England and Wales. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/598401/ Salmonella_2016_Data.pdf.
13. Gillespie IA, O’Brien SJ, Adak GK, Ward LR, Smith HR. 2005. Foodborne general outbreaks of Salmonella Enteritidis phage type 4 infection, England and Wales, 1992-2002: where are the risks? Epidemiol Infect 133:795–801. https://doi.org/10.1017/S0950268805004474.
14. O’Brien SJ. 2013. The “decline and fall” of nontyphoidal salmonella in the United Kingdom. Clin Infect Dis 56:705–710. https://doi.org/10.1093/cid/cis967.
15. Braden CR. 2006. Salmonella enterica serotype Enteritidis and eggs: a national epidemic in the United States. Clin Infect Dis 43:512–517. https://doi.org/10.1086/505973.
16. European Centers for Disease Prevention and Control and the European Food Safety Agency. 2015. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2013. EFSA J 13(1):3991. https://doi.org/10.2903/j.efsa.2015.3991.
17. Moffatt CR, Musto J, Pingault N, Miller M, Stafford R, Gregory J, Polking-horne BG, Kirk MD. 2016. Salmonella Typhimurium and outbreaks of egg-associated disease in Australia, 2001 to 2011. Foodborne Pathog Dis 13:379 –385. https://doi.org/10.1089/fpd.2015.2110.
18. Centers for Disease Prevention and Control. 2016. National enteric disease surveillance: Salmonella annual report, 2013. https://www.cdc.gov/nationalsurveillance/pdfs/salmonella-annual-report-2013-508c.pdf.
19. Ashbolt R, Kirk MD. 2006. Salmonella Mississippi infections in Tasmania: the role of native Australian animals and untreated drinking water. Epidemiol Infect 134:1257–1265. https://doi.org/10.1017/S0950268806006224.
20. European Food Safety Authority and European Centre for Disease Prevention and Control. 2016. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014. EFSA J 14(2):4380.
21. Cheng AC, Turnidge J, Collignon P, Looke D, Barton M, Gottlieb T. 2012. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 18:1453–1460. https://doi.org/10.3201/eid1809.111515.
22. Cavaco LM, Hendriksen RS, Aarestrup FM. 2007. Plasmid-mediated quin-olone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand. J Antimicrob Chemother 60:704–706. https://doi.org/10.1093/jac/dkm261.
23. Veldman K, van Pelt W, Mevius D. 2008. First report of qnr genes in Salmonella in The Netherlands. J Antimicrob Chemother 61:452–453. https://doi.org/10.1093/jac/dkm495.
24. Langridge GC, Nair S, Wain J. 2009. Nontyphoidal Salmonella serovars cause different degrees of invasive disease globally. J Infect Dis 199: 602–603. https://doi.org/10.1086/596208.
25. Angelo KM, Reynolds J, Karp BE, Hoekstra RM, Scheel CM, Friedman C. 2016. Antimicrobial resistance among nontyphoidal Salmonella isolated from blood in the United States, 2003-2013. J Infect Dis 214:1565–1570. https://doi.org/10.1093/infdis/jiw415.
26. Huang JY, Henao OL, Griffin PM, Vugia DJ, Cronquist AB, Hurd S, Tobin-D’Angelo M, Ryan P, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Wolpert BJ, Patrick ME. 2016. Infection with pathogens transmitted commonly through food and the effect of increasing use of culture-independent diagnostic tests on surveillance—foodborne diseases active surveillance network, 10 U.S. sites, 2012-2015. MMWR Morb Mortal Wkly Rep 65:368–371. https://doi.org/ 10.15585/mmwr.mm6514a2.
27. Guibourdenche M, Roggentin P, Mikoleit M, Fields PI, Bockemuhl J, Grimont PA, Weill FX. 2010. Supplement 2003-2007 (No. 47) to the White-Kauffmann-Le Minor scheme. Res Microbiol 161:26–29. https://doi.org/10.1016/j.resmic.2009.10.002.
28. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x.
29. Commons RJ, McBryde E, Valcanis M, Powling J, Street A, Hogg G. 2012. Twenty-six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistance. Med J Aust 196:332–336. https://doi.org/10.5694/mja12.10082.